SCHEMBL31727353

SCHEMBL31727353

O=[N+]([O-])c1ncc(Br)cc1N1CCC(O)CC1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
ALDH1A1 P00352 5/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MAPK1 P28482 1/20 0.37
CSF1R P07333 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
OPRK1 P41145 5/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM4E B2RXH2 2/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
POLB P06746 1/20 0.34
PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31727323 0.92 LMNA (0.40) MAPTALDH1A1MEN1KMT2AHSP90AA1
SCHEMBL31727264 0.92 LMNA (0.40) MAPTALDH1A1MEN1KMT2AHSP90AA1
SCHEMBL31728420 0.86 MAPT (0.33) MAPTALDH1A1MEN1KMT2AOPRK1
SCHEMBL31727796 0.84 MAPT (0.46) MAPTALDH1A1HSP90AA1MAPK1L3MBTL1
SCHEMBL31727712 0.84 MAPT (0.42) MAPTALDH1A1HSP90AA1MAPK1L3MBTL1
SCHEMBL31727072 0.83 MAPT (0.39) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL31727985 0.81 PDE10A (0.38) KMT2ACSF1ROPRK1
SCHEMBL31727588 0.80 MAPT (0.36) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL31728428 0.79 MAPT (0.34) MAPTALDH1A1MEN1KMT2AMAPK1
SCHEMBL30856655 0.78 SCN10A (0.36) MAPTALDH1A1MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025231561-A1 TERTIARY AMINE-SUBSTITUTED BIPYRIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND THEIR USE AS PHARMACEUTICALS UNIVERSITE DE MONTREAL (CA) 2025-11-13 WO disclosed